Cargando…

Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation

OBJECTIVE: High oxidative stress potentially leads to accelerated telomere shortening and consequent premature cell senescence, implicated in type 2 diabetes (T2D) development. Therefore, we studied the association of leukocyte telomere length (LTL) with the presence of T2D, as well as the effect on...

Descripción completa

Detalles Bibliográficos
Autores principales: Salpea, Klelia D., Talmud, Philippa J., Cooper, Jackie A., Maubaret, Cecilia G., Stephens, Jeffrey W., Abelak, Kavin, Humphries, Steve E.
Formato: Texto
Lenguaje:English
Publicado: Elsevier 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839074/
https://www.ncbi.nlm.nih.gov/pubmed/19889414
http://dx.doi.org/10.1016/j.atherosclerosis.2009.09.070
_version_ 1782178917309743104
author Salpea, Klelia D.
Talmud, Philippa J.
Cooper, Jackie A.
Maubaret, Cecilia G.
Stephens, Jeffrey W.
Abelak, Kavin
Humphries, Steve E.
author_facet Salpea, Klelia D.
Talmud, Philippa J.
Cooper, Jackie A.
Maubaret, Cecilia G.
Stephens, Jeffrey W.
Abelak, Kavin
Humphries, Steve E.
author_sort Salpea, Klelia D.
collection PubMed
description OBJECTIVE: High oxidative stress potentially leads to accelerated telomere shortening and consequent premature cell senescence, implicated in type 2 diabetes (T2D) development. Therefore, we studied the association of leukocyte telomere length (LTL) with the presence of T2D, as well as the effect on the patients’ LTL of plasma oxidative stress and of variation in UCP2, a gene involved in the mitochondrial production of reactive oxygen species. METHODS: Mean LTL was determined in 569 Caucasian, 103 South Asian and 70 Afro-Caribbean T2D patients aged from 24 to 92 years, 81 healthy Caucasian male students aged from 18 to 28 years and 367 healthy Caucasian men aged from 40 to 61 years by real-time PCR. Plasma total antioxidant status (TAOS) was measured in the T2D patients by a photometric microassay. The patients were also genotyped for the UCP2 functional variants −866G>A and A55V. RESULTS: Afro-Carribeans had 510 bp longer mean length compared to Caucasians (p < 0.0001) and 500 bp longer than South Asians (p = 0.004). T2D subjects displayed shorter age-adjusted LTL compared to controls [6.94(6.8–7.03) vs. 7.72(7.53–7.9), p < 0.001] with subjects in the middle and the lowest tertile of LTL having significantly higher odds ratios for T2D compared to those in the highest tertile [1.50(1.08–2.07) and 5.04(3.63–6.99), respectively, p < 0.0001]. In the patients, LTL was correlated negatively with age (r = −0.18, p < 0.0001) and positively with TAOS measures (r = 0.12, p = 0.01) after adjusting for age, while carriers of the UCP2 −866A allele had shorter age-adjusted LTL than common homozygotes [6.86(6.76–6.96) kb vs. 7.03(6.91–7.15) kb, p = 0.04]. CONCLUSION: The present data suggest that shorter LTL is associated with the presence of T2D and this could be partially attributed to the high oxidative stress in these patients. The association of the UCP2 functional promoter variant with the LTL implies a link between mitochondrial production of reactive oxygen species and shorter telomere length in T2D.
format Text
id pubmed-2839074
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-28390742010-03-31 Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation Salpea, Klelia D. Talmud, Philippa J. Cooper, Jackie A. Maubaret, Cecilia G. Stephens, Jeffrey W. Abelak, Kavin Humphries, Steve E. Atherosclerosis Article OBJECTIVE: High oxidative stress potentially leads to accelerated telomere shortening and consequent premature cell senescence, implicated in type 2 diabetes (T2D) development. Therefore, we studied the association of leukocyte telomere length (LTL) with the presence of T2D, as well as the effect on the patients’ LTL of plasma oxidative stress and of variation in UCP2, a gene involved in the mitochondrial production of reactive oxygen species. METHODS: Mean LTL was determined in 569 Caucasian, 103 South Asian and 70 Afro-Caribbean T2D patients aged from 24 to 92 years, 81 healthy Caucasian male students aged from 18 to 28 years and 367 healthy Caucasian men aged from 40 to 61 years by real-time PCR. Plasma total antioxidant status (TAOS) was measured in the T2D patients by a photometric microassay. The patients were also genotyped for the UCP2 functional variants −866G>A and A55V. RESULTS: Afro-Carribeans had 510 bp longer mean length compared to Caucasians (p < 0.0001) and 500 bp longer than South Asians (p = 0.004). T2D subjects displayed shorter age-adjusted LTL compared to controls [6.94(6.8–7.03) vs. 7.72(7.53–7.9), p < 0.001] with subjects in the middle and the lowest tertile of LTL having significantly higher odds ratios for T2D compared to those in the highest tertile [1.50(1.08–2.07) and 5.04(3.63–6.99), respectively, p < 0.0001]. In the patients, LTL was correlated negatively with age (r = −0.18, p < 0.0001) and positively with TAOS measures (r = 0.12, p = 0.01) after adjusting for age, while carriers of the UCP2 −866A allele had shorter age-adjusted LTL than common homozygotes [6.86(6.76–6.96) kb vs. 7.03(6.91–7.15) kb, p = 0.04]. CONCLUSION: The present data suggest that shorter LTL is associated with the presence of T2D and this could be partially attributed to the high oxidative stress in these patients. The association of the UCP2 functional promoter variant with the LTL implies a link between mitochondrial production of reactive oxygen species and shorter telomere length in T2D. Elsevier 2010-03 /pmc/articles/PMC2839074/ /pubmed/19889414 http://dx.doi.org/10.1016/j.atherosclerosis.2009.09.070 Text en © 2010 Elsevier Ireland Ltd. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license
spellingShingle Article
Salpea, Klelia D.
Talmud, Philippa J.
Cooper, Jackie A.
Maubaret, Cecilia G.
Stephens, Jeffrey W.
Abelak, Kavin
Humphries, Steve E.
Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation
title Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation
title_full Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation
title_fullStr Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation
title_full_unstemmed Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation
title_short Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation
title_sort association of telomere length with type 2 diabetes, oxidative stress and ucp2 gene variation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839074/
https://www.ncbi.nlm.nih.gov/pubmed/19889414
http://dx.doi.org/10.1016/j.atherosclerosis.2009.09.070
work_keys_str_mv AT salpeakleliad associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation
AT talmudphilippaj associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation
AT cooperjackiea associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation
AT maubaretceciliag associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation
AT stephensjeffreyw associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation
AT abelakkavin associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation
AT humphriesstevee associationoftelomerelengthwithtype2diabetesoxidativestressanducp2genevariation